It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

Prostate tumors contain more microplastics than healthy prostate tissue, researchers from New York University Langone Health ...

Artificial intelligence has bounded into the mainstream, into personal lives, classroom assignments and work meetings — so it should be no surprise to find it in doctors’ offices and emergency ...

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few drops of semen or blood in the long term. Prostate cancer is the most common ...

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release. As Healio previously reported, ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agentcombines thediagnostic performance of PYLARIFY® (piflufolastat F 18) ...

Men receiving treatment for prostate cancer often face challenges that extend well beyond the disease itself. A new study led ...

New research suggests that an existing blood test may help to determine when someone is likely to develop Alzheimer's disease ...

If you really want to knock out for eight hours of uninterrupted bliss, the best sleep aid isn’t in your medicine cabinet — it’s in your nightstand. Put down the melatonin and pick up a vibrator, ...